Navegando por Assunto "Insulina"

Agora exibindo 1 - 2 de 2

Avaliação do controle glicêmico a partir da quantidade de carboidrato ingerido por dia pelos pacientes acompanhados no ambulatório de Diabetes Mellitus tipo 1 do Centro de Especialidades Médicas do Centro Universitário do Estado do Pará
(Centro Universitário do Estado do Pará, 2020) Souza, Júlia Corrêa Campos de; Scalfoni, Viviana Virgínia Bezerra; Santos, Flávia Marques; Bastos, Fabíola de Arruda; http://lattes.cnpq.br/9386935778704228; http://lattes.cnpq.br/8601394323526613
INTRODUCTION: Recent evidence suggests a strong relationship between the nutritional factor and the control of type 1 diabetes mellitus (DM1) and Latent Autoimmune Diabetes in Adults (LADA). OBJECTIVE: To evaluate glycemic control based on dietary diagnosis in patients with DM1 and LADA. METHODS: Cross-sectional study with patients with DM1 and LADA followed up at the clinical research and endocrinology service of CEMEC-CESUPA, data were collected from medical records on daily nutrition, anthropometric data and glycemic control. RESULTS: 71 patients were eligible for the 60,6% were female; the majority in the age group between 18-28 years, had a time of diagnosis between 1-11 years. Regarding insulin therapy, 77.5% used a basal bolus regimen and 9.8% were on another insulin regimen, 88.7% were on a fixed dose of insulin, while 11.3% used a variable dose of insulin by counting carbohydrates. Those in fixed dose showed a variation of HbA1C 8.6 ± 1.8% and fasting glucose between 189.3 ± 69.3 (mg / dl). Variable dose patients had HbA1C between 7.7 ± 0.84% and fasting blood glucose between 159.8 ± 55.9 (mg / dl), thus a tendency towards better glycemic control was observed among patients on a variable dose of insulin. Regarding physical activity, 37 patients did not exercise regularly. The average amount of carbohydrates eaten daily by patients was 196.8 ± 86.6g. As for fiber consumption, 36 patients (50.7%) took it 0-1 times a day, 29 (40.9%) 2-3 times a day and only 6 (8.4%) 4-5 times a day. day. The individual Basal Metabolic Rate (BMR), calculated using the Harris-Benedict formula, showed that 43 patients (60%) had an intake less than or equal to the ideal kilocalorie (kcal) of their respective BMR. CONCLUSION: This study concludes that there is a favorable glycemic control from the consumption of CHO with an intake of less than 60% of TBM. Carbohydrate counting patients achieved better glycemic control, starting from HbA1C and fasting glycemia, when compared to patients using a fixed dose. In view of this, it is possible to stimulate the education of the population cared for in the outpatient clinic for the counting of carbohydrates, not forgetting the beneficial influence of the association with the practice of regular physical exercise, in order to reduce future complications and promote a better quality of life for them.
Avaliação do impacto da utilização do sistema de infusão contínua de insulina na qualidade de vida de pacientes portadores de Diabetes Mellitus do tipo 1
(Centro Universitário do Estado do Pará, 2023-05-30) Monteiro, Demmy Chaves Amaral; Chaves, Michelle Luiza da Silva; Santos, Flávia Marques; http://lattes.cnpq.br/8601394323526613; Rocha, Mônica Souza Filho Moura; http://lattes.cnpq.br/1302412321438738; Miranda, Nádia Costa de; http://lattes.cnpq.br/6968956833621813
Type 1 Diabetes Mellitus (DM1) is a chronic autoimmune disease with a genetic determinant in which there is an absence or deficiency in the production of insulin, which regulates blood glucose and provides energy for the body. People with this disease are permanently dependent on exogenous insulin for homeostasis of glucose metabolism. The treatment to replenish insulin stocks is usually uncomfortable, presenting certain limitations to daily life. One way to minimize the negative impact of therapy and improve quality of life (QoL) is through the continuous insulin infusion system. To evaluate the quality of life with the use of the Continuous Insulin Infusion System in patients with Type 1 Diabetes Mellitus in the DM1 outpatient clinic of the Medical Specialties Center of CESUPA. Cross-sectional study that evaluates, through a modified questionnaire, the quality of life of 8 patients of both sexes, with DM1, in use of SICI for at least 6 months, accompanied at the Medical Specialties Center of CESUPA (CEMEC). Satisfaction with treatment assessed by part I of the questionnaire is high, with a value of 75% very satisfied and 25% satisfied. Of the analyzed subscales, “Impact on Social Life" is the one that presents the least satisfaction (62.5%) and “Well-being” is the one that presents the greatest satisfaction (100%). “decrease in the number of punctures” (37.5%) and “better glycemic control” (25%). In points of displeasure, “nothing” is reported in 37.5% of patients. 62.5% of patients had a total of 0 episodes of severe hypoglycemia in the last year, and 50% had an average decrease of 0.6-1 in HbA1c from the first year of pump placement compared to the year of the survey. Regarding quality of life, 75% of the patients obtained “Excellent” and 25% “Good” QoL, with a result of 120.6 ‡14.4. This study reveals a high QoL index for this sample of patients, ranging from “good” to “excellent”. The joint analysis of satisfaction with treatment and clinical data revealed that not only do patients have a positive perception of treatment in different areas of life, but also the positivity is proven by clinical data.